share_log

Groupon Analyst Ratings

Benzinga ·  Aug 11, 2023 07:11
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/11/2023 -47.33% Goldman Sachs $3 → $4 Maintains Sell
08/10/2023 -21% Barclays $4 → $6 Maintains Underweight
05/12/2023 -55.23% Credit Suisse $12 → $3.4 Maintains Neutral
03/20/2023 -47.33% Barclays $7 → $4 Maintains Underweight
03/20/2023 -40.75% Goldman Sachs $6.5 → $4.5 Maintains Sell
03/17/2023 58% Credit Suisse $15 → $12 Maintains Neutral
11/08/2022 -14.42% Goldman Sachs $10 → $6.5 Maintains Sell
11/08/2022 -21% Barclays $10 → $6 Maintains Underweight
11/08/2022 97.5% Credit Suisse $18 → $15 Maintains Neutral
08/10/2022 137% Credit Suisse $23 → $18 Maintains Neutral
08/10/2022 31.67% Barclays $12 → $10 Maintains Underweight
05/11/2022 59.32% Goldman Sachs $20 → $12.1 Maintains Sell
05/10/2022 58% Barclays $20 → $12 Maintains Underweight
05/10/2022 202.83% Credit Suisse $29 → $23 Maintains Neutral
03/24/2022 295% Ascendiant Capital $35 → $30 Maintains Buy
03/02/2022 281.83% Credit Suisse $38 → $29 Maintains Neutral
12/23/2021 360.83% Ascendiant Capital $40 → $35 Maintains Buy
12/15/2021 268.66% JP Morgan $38 → $28 Maintains Neutral
12/10/2021 202.83% Barclays $30 → $23 Maintains Underweight
08/09/2021 295% Barclays $35 → $30 Maintains Underweight
08/09/2021 400.33% Credit Suisse $42 → $38 Maintains Neutral
03/01/2021 531.99% JP Morgan → $48 Upgrades Underweight → Neutral
03/01/2021 360.83% Credit Suisse $31 → $35 Maintains Neutral
01/15/2021 347.66% Morgan Stanley $21 → $34 Maintains Equal-Weight
11/09/2020 308.16% Credit Suisse $30 → $31 Maintains Neutral
11/02/2020 176.5% Wedbush $27 → $21 Maintains Neutral
10/15/2020 176.5% Morgan Stanley $22 → $21 Maintains Equal-Weight
08/10/2020 295% Credit Suisse $32 → $30 Maintains Neutral
08/10/2020 321.33% UBS $30 → $32 Maintains Buy
06/19/2020 189.66% Morgan Stanley $18 → $22 Maintains Equal-Weight
05/07/2020 -88.15% Morgan Stanley $1.5 → $0.9 Maintains Equal-Weight
04/21/2020 -80.25% UBS $2.9 → $1.5 Maintains Buy
04/14/2020 -78.93% Credit Suisse $2 → $1.6 Maintains Neutral
02/21/2020 -80.25% Morgan Stanley $2.8 → $1.5 Maintains Equal-Weight
02/20/2020 -73.67% Credit Suisse $4 → $2 Maintains Neutral
02/20/2020 -61.82% UBS $3.5 → $2.9 Maintains Buy
02/20/2020 -76.96% Wedbush $3 → $1.75 Maintains Neutral
01/17/2020 -53.92% UBS → $3.5 Upgrades Neutral → Buy
12/23/2019 -57.21% Ascendiant Capital $4.25 → $3.25 Maintains Buy
12/17/2019 -68.4% Goldman Sachs → $2.4 Downgrades Neutral → Sell
11/06/2019 JP Morgan Downgrades Neutral → Underweight
02/04/2019 -53.92% Goldman Sachs → $3.5 Initiates Coverage On → Neutral
09/14/2018 -47.33% Wedbush → $4 Initiates Coverage On → Neutral

What is the target price for Groupon (GRPN)?

The latest price target for Groupon (NASDAQ: GRPN) was reported by Goldman Sachs on August 11, 2023. The analyst firm set a price target for $4.00 expecting GRPN to fall to within 12 months (a possible -47.33% downside). 9 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Groupon (GRPN)?

The latest analyst rating for Groupon (NASDAQ: GRPN) was provided by Goldman Sachs, and Groupon maintained their sell rating.

When is the next analyst rating going to be posted or updated for Groupon (GRPN)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Groupon, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Groupon was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.

Is the Analyst Rating Groupon (GRPN) correct?

While ratings are subjective and will change, the latest Groupon (GRPN) rating was a maintained with a price target of $3.00 to $4.00. The current price Groupon (GRPN) is trading at is $7.60, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment